Coverage
-
February 20, 2015
Impax Laboratories Inc. has reached an $8 million settlement with a class of shareholders who allege that the company downplayed U.S. Food and Drug Administration concerns over quality control at a California plant, it was announced Friday.
2 other articles on this case.
View all »